Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 5
2013 1
2018 1
2019 1
2020 2
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Adameros
Page 1
Impact of Antipsychotic Guidelines on Laboratory Monitoring in Children with Neurodevelopmental Disorders.
Kara I, Penner M. Kara I, et al. J Child Adolesc Psychopharmacol. 2021 Feb;31(1):79-83. doi: 10.1089/cap.2020.0096. Epub 2020 Oct 14. J Child Adolesc Psychopharmacol. 2021. PMID: 33052712 Free PMC article.
SGA monitoring data were missing in 40% of charts pre-CAMESA and in 31% of charts post-CAMESA. The proportion of patients with any available laboratory monitoring did not change between the time periods (35% pre-CAMESA vs. 39% post-CAMESA; p = 0.56). S …
SGA monitoring data were missing in 40% of charts pre-CAMESA and in 31% of charts post-CAMESA. The proportion of patients with …
Long-Term Metabolic Monitoring of Youths Treated with Second-Generation Antipsychotics 5 Years after Publication of the CAMESA Guidelines Are We Making Progress? Surveillance Metabolique a Long Terme des Jeunes Traites par Antipsychotiques de Deuxieme Generation, Cinq ans Apres la publication des Lignes Directrices Camesa: Faisons-Nous des Progres?
Jazi S, Ben-Amor L, Abadie P, Menard ML, Choquette R, Berthiaume C, Mottron L, Ilies D. Jazi S, et al. Can J Psychiatry. 2021 Jul;66(7):645-656. doi: 10.1177/0706743720974847. Epub 2020 Nov 26. Can J Psychiatry. 2021. PMID: 33243011 Free PMC article.
The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics (CAMESA) offers guidelines for this purpose. We aimed to evaluate the long-term rates of youths receiving monitoring in mental health clinics and document the factors that may influence them. . …
The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics (CAMESA) offers guidelines for this purpose. We aimed …
Adherence to antipsychotic laboratory monitoring guidelines in children and youth: a population-based study.
Antoniou T, Wang T, Pajer K, Gardner W, Lunsky Y, Penner M, Tadrous M, Mamdani M, Juurlink DN, Gomes T. Antoniou T, et al. Front Psychiatry. 2023 May 12;14:1172559. doi: 10.3389/fpsyt.2023.1172559. eCollection 2023. Front Psychiatry. 2023. PMID: 37252150 Free PMC article.
BACKGROUND: In 2011, the Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) published guidelines for the metabolic monitoring of antipsychotic-treated children and youth. ...
BACKGROUND: In 2011, the Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) published g …
Adherence to Antipsychotic Adverse Effect Monitoring Among a Referred Sample of Children with Intellectual Disabilities.
Javaheri KR, McLennan JD. Javaheri KR, et al. J Child Adolesc Psychopharmacol. 2019 Apr;29(3):235-240. doi: 10.1089/cap.2018.0167. Epub 2019 Feb 27. J Child Adolesc Psychopharmacol. 2019. PMID: 30810348
Charts of all those on antipsychotic medications were reviewed for a 12-week period to determine the extent to which adverse effect monitoring was documented using the parameters stipulated by the Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Chil …
Charts of all those on antipsychotic medications were reviewed for a 12-week period to determine the extent to which adverse effect monitori …
Monitoring of metabolic adverse events of second-generation antipsychotics in a naive paediatric population followed in mental health outpatient and inpatient clinical settings: MEMAS prospective study protocol.
Menard ML, Ilies D, Abadie P, Jean-Baptiste T, Choquette R, Huet AS, Ben Amor L. Menard ML, et al. BMJ Open. 2021 Jan 17;11(1):e040764. doi: 10.1136/bmjopen-2020-040764. BMJ Open. 2021. PMID: 33455928 Free PMC article.
The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in children (CAMESA) has published recommendations for monitoring the metabolic AEs of SGAs. ...The objectives of our research are to evaluate some factors that can influence the development of …
The Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in children (CAMESA) has published recommendations fo …
Patient, Treatment, and Health Care Utilization Variables Associated with Adherence to Metabolic Monitoring Practices in Children and Adolescents Taking Second-Generation Antipsychotics.
Coughlin M, Goldie CL, Tranmer J, Khalid-Khan S, Tregunno D. Coughlin M, et al. Can J Psychiatry. 2018 Apr;63(4):240-249. doi: 10.1177/0706743717751693. Epub 2018 Mar 11. Can J Psychiatry. 2018. PMID: 29528720 Free PMC article.
This study aims to explore what patient, treatment, and health care utilization variables are associated with adherence to Canadian Alliance for Monitoring Effectiveness and Safety of Antipsychotics in Children (CAMESA) metabolic monitoring guidelines. METHOD: A retrospect …
This study aims to explore what patient, treatment, and health care utilization variables are associated with adherence to Canadian Alliance …
12 results